The Immune Response to Influenza Vaccinations in Elderly Individuals
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to characterize the immune profile of frail and healthy aged
individuals and investigate their immune responsiveness including the response to influenza
vaccine over an 18-month period. The project will include a longitudinal study to define
immune signatures and multi-parameter profiles associated with frailty and may lead to the
identification of predictive markers of evolution to frailty and Immunosenescence in the
elderly.
Phase:
Phase 4
Details
Lead Sponsor:
National University Hospital, Singapore
Collaborators:
Agency for Science, Technology and Research National University, Singapore Sanofi Pasteur, a Sanofi Company